A single course of rituximab does not abrogate anti-infliximab antibodies in patients with rheumatoid arthritis.
van den Bemt BJ, Vos K, den Broeder AA, Blom M, Thurlings RM, Bartelds GM, Stapel SO, Barrera P, Tak PP, Nurmohamed MT, Wolbink GJ.
van den Bemt BJ, et al. Among authors: den broeder aa.
Ann Rheum Dis. 2009 Aug;68(8):1368-9. doi: 10.1136/ard.2008.095448.
Ann Rheum Dis. 2009.
PMID: 19605744
Free article.
Clinical Trial.
No abstract available.